Personalized blood glucose (BG) prediction in Type 1 Diabetes (T1D) is challenged by significant inter-patient heterogeneity. To address this, we propose BiT-MAML, a hybrid model combining a Bidirectional LSTM-Transformer with Model-Agnostic Meta-Lea...
The accurate prediction of blood glucose is critical for the effective management of diabetes. Modern continuous glucose monitoring (CGM) technology enables real-time acquisition of interstitial glucose concentrations, which can be calibrated against...
Elevated postprandial glucose levels present a global epidemic and a major challenge in type-2 diabetes (T2D) management. A key barrier to developing effective dietary interventions for T2D management is the wide inter-individual variation in glycemi...
BACKGROUND: There is uncertainty regarding the association between continuous glucose monitoring (CGM), derived glycemic metrics, and metabolic dysfunction-associated steatotic liver disease (MASLD) in individuals with type 1 diabetes (T1D).
BACKGROUND: This study employed representative data from the U.S. and China to delve into the correlation among migraine prevalence, the triglyceride‒glucose index, a marker of insulin resistance, and the composite indicator of obesity.
In general, deficient birth weight neonates suffer from hypoglycemia, and this can be quite disadvantageous. Like oxygen, glucose is a building block of life and constitutes the significant share of energy produced by the fetus and the neonate during...
Monitoring of fasting blood sugar (FBS) is a critical component in the diagnosis and management of diabetes, one of the most widespread chronic diseases globally. Microwave sensing-particularly through microstrip-based sensors-has recently gained att...
Biomarkers are crucial in aiding in disease diagnosis, prognosis, and treatment selection. Machine learning (ML) has emerged as an effective tool for identifying novel biomarkers and enhancing predictive modelling. However, sex-based bias in ML algor...
Journal of diabetes science and technology
Jul 1, 2025
BACKGROUND: Since the discovery of the life-saving hormone insulin in 1921 by Dr Frederick Banting in 1921, there have been many critical discoveries and technical breakthroughs that have enabled people living with type 1 diabetes (T1D) to live longe...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.